Home/ Supplements/ Omega 3/ Multivitamins for Women - with Fish Oil ...

Multivitamins for Women - with Fish Oil Softgels

product on market Softgel Capsule BulkSupplements.com Safety: 97/100
97/100

This product looks safe

  • Folic Acid: 667mg is 667.0× the Tolerable Upper Intake Level (1.0mg)
  • Molybdenum: 25.5mg is 12.8× the Tolerable Upper Intake Level (2mg)
  • 67% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

The profile includes essential vitamins A, B6, B12, C, and E, which support immune function and metabolic processes. There is strong research evidence for the role of these micronutrients in maintaining general health. The formulation maintains a high safety score, indicating a low risk of adverse effects.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folic Acid: 667mg is 667.0× the Tolerable Upper Intake Level (1.0mg)

Molybdenum: 25.5mg is 12.8× the Tolerable Upper Intake Level (2mg)

Label

Product Label

Label for Multivitamins for Women - with Fish Oil Softgels
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
90
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
937.5 mcg RAE (104% DV)
2.5 mg (147% DV)
1.9× RDA — within safe limits 114 studies (A:3, B:35)
10 mcg (417% DV)
4.2× RDA — above typical dose 139 studies (A:1, B:44)
Vitamin C
30 mg (33% DV)
14.75 mg (98% DV)
Within RDA (1.0× RDA) 179 studies (A:3, B:90)
Iron
2.5 mg (14% DV)
11.25 mcg (56% DV)
Within RDA (0.8× RDA) 608 studies (A:16, B:251)
55 mcg (100% DV)
Within RDA (1.0× RDA) 173 studies (A:0, B:67)
2.5 mg (208% DV)
2.1× RDA — within safe limits 76 studies (A:0, B:33)
2.5 mg (192% DV)
1.9× RDA — within safe limits 13 studies (A:0, B:1)
667 mcg DFE (166% DV)
Exceeds UL by 667.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
4.4 mg (88% DV)
Within RDA (0.9× RDA) 2 studies — no high-quality reviews
Calcium
23 mg (1.8% DV)
25 mg (6% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
3.75 mg (34% DV)
Within RDA (0.3× RDA) 263 studies (A:6, B:134)
10 mg NE (63% DV)
Within RDA (0.7× RDA) 196 studies (A:5, B:63)
25.5 mg (5% DV)
Exceeds UL by 12.8× (UL: 2 mg) 3 studies — no high-quality reviews
25 mg (5% DV)
Market median: 125.0mg (294 products) 38 studies (A:1, B:7)
500 mcg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Fish Oil Soybean Oil Beeswax Gelatin Water
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 1 softgel once daily, or as directed by a physician.

Warnings & Precautions

Always consult a physician before taking any dietary supplement.

Keep out of reach of children.

Allergen information: contains fish, soy

Formulation Notes

Multivitamins 1000mg per serving

Free of: Added sugar, dairy, yeast

Softgels for women

Additional Information

Store in a dry, cool place

New

Scan me

Metadata

Product Details

UPC / SKUX003OCRJS3
DSLD Entry Date2024-04-23
Product TypeOther Combinations
FormSoftgel Capsule
BrandBulkSupplements.com
DSLD ID312980
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

Non-Fish Vegan Omega-3 DHA
DEVA · Softgel Capsule
100
Algal-900 DHA
Spring Valley · Softgel Capsule
100
Ultra Omega
HoltraCeuticals · Softgel Capsule
100
Pre & Post Natal DHA 100 mg
Vitamin World · Softgel Capsule
100
Triple Fish Oil 1000 mg
Nature's Harmony · Softgel Capsule
100
View all Omega 3 products →
Omega 3 research Best Omega 3 All Omega 3 products More from BulkSupplements.com View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.